Compounds > triazoles
Page last updated: 2024-08-24

triazoles and echinocandin b

triazoles has been researched along with echinocandin b in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's9 (90.00)29.6817
2010's1 (10.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Colebunders, R; Ieven, M; Noë, A; Ostyn, B; Swinne, D1
Chandra, J; George, T; Ghannoum, MA; Kuhn, DM; Mukherjee, PK1
Kontoyiannis, DP; Mantadakis, E; Samonis, G1
Gea-Banacloche, JC; Glasmacher, A; Groll, AH; Just-Nuebling, G; Maschmeyer, G; Walsh, TJ1
Bliss, JM; Gigliotti, F; Wellington, M1
Perfect, JR1
Benjamin, DK; Steinbach, WJ; Zaoutis, TE1
Kontoyiannis, DP; Lewis, RE1
Baker, CJ; Pannaraj, PS; Walsh, TJ1
Elefanti, A; Meletiadis, J; Mouton, JW; Tsakris, A; Verweij, PE; Zerva, L1

Reviews

5 review(s) available for triazoles and echinocandin b

ArticleYear
Systemic mycoses in the immunocompromised host: an update in antifungal therapy.
    The Journal of hospital infection, 2003, Volume: 53, Issue:4

    Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Candidiasis; Deoxycholic Acid; Drug Combinations; Echinocandins; Fungal Proteins; Humans; Immunocompromised Host; Mycoses; Peptides; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Triazoles

2003
Clinical pharmacology of antifungal compounds.
    Infectious disease clinics of North America, 2003, Volume: 17, Issue:1

    Topics: Anti-Bacterial Agents; Antifungal Agents; Drug Design; Echinocandins; Flucytosine; Fungal Proteins; Humans; Immunocompromised Host; Molecular Structure; Mycoses; Peptides; Peptides, Cyclic; Polyenes; Triazoles

2003
Antifungal pharmacotherapy for neonatal candidiasis.
    Seminars in perinatology, 2003, Volume: 27, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Cross Infection; Echinocandins; Fluconazole; Flucytosine; Fungal Proteins; Fungemia; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Ketoconazole; Lipopeptides; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2003
Management of invasive mycoses in hematology patients: current approaches.
    Oncology (Williston Park, N.Y.), 2004, Volume: 18, Issue:13 Suppl 7

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Resistance, Fungal; Echinocandins; Fungal Proteins; Hematopoietic Stem Cell Transplantation; Humans; Liposomes; Mycoses; Neoplasms; Neutropenia; Peptides, Cyclic; Randomized Controlled Trials as Topic; Survival Analysis; Triazoles

2004
Antifungal treatment in pediatric patients.
    Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 2005, Volume: 8, Issue:4

    Topics: Adolescent; Amphotericin B; Antifungal Agents; Azoles; Caspofungin; Child; Child, Preschool; Drug Resistance, Fungal; Echinocandins; Flucytosine; Fungal Proteins; Humans; Infant; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Triazoles

2005

Other Studies

5 other study(ies) available for triazoles and echinocandin b

ArticleYear
A multidrug, including voriconazole, resistant oral Candida infection in an AIDS patient effectively treated with echinocandin.
    The Journal of infection, 2002, Volume: 44, Issue:1

    Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antifungal Agents; Drug Resistance, Multiple, Fungal; Echinocandins; Fungal Proteins; Humans; Male; Peptides; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2002
Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:6

    Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Biofilms; Candida; Culture Media; Drug Resistance, Microbial; Echinocandins; Fungal Proteins; Liposomes; Microbial Sensitivity Tests; Microscopy, Confocal; Peptides; Peptides, Cyclic; Polyenes; Prosthesis-Related Infections; Triazoles

2002
Micafungin in combination with voriconazole in Aspergillus species: a pharmacodynamic approach for detection of combined antifungal activity in vitro.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:5

    Topics: Antifungal Agents; Aspergillus; Drug Combinations; Echinocandins; Fluorescence; Fungal Proteins; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Microscopy, Fluorescence; Peptides, Cyclic; Pyrimidines; Staining and Labeling; Triazoles; Voriconazole

2005
Advances in antifungal therapy.
    The Pediatric infectious disease journal, 2005, Volume: 24, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Animals; Antifungal Agents; Caspofungin; Child; Child, Preschool; Clinical Trials as Topic; Echinocandins; Fungal Proteins; Humans; Infant; Infant, Newborn; Lipopeptides; Lipoproteins; Micafungin; Middle Aged; Mycoses; Peptides, Cyclic; Pyrimidines; Thiazoles; Treatment Outcome; Triazoles; Voriconazole

2005
Amphotericin B- and voriconazole-echinocandin combinations against Aspergillus spp.: Effect of serum on inhibitory and fungicidal interactions.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:10

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Drug Interactions; Echinocandins; Fungal Proteins; Humans; Microbial Sensitivity Tests; Pyrimidines; Serum; Triazoles; Voriconazole

2013